BridgeBio Oncology Therapeutics, Inc.

BBOT

$8.23▲ 2.49% 24h

Advanced chart & tools →

BridgeBio Oncology Therapeutics, Inc.BBOT

$8.23

+$4.78(+138.48%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

$658.67M

P/E ratio

—

EPS (diluted)

$-4.30

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

—

Net income

$-134.04M

Net margin

—

Gross margin

—

Dividends & financials

BridgeBio Oncology Therapeutics, Inc. (BBOT) reported revenue of — and net income of $-134.04M, or $-4.30 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.